Drug Discovery
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Jubilant Biosys, Sanofi Expand Collaboration
Collaboration aimed at discovery of small molecule inhibitors targeting neurological disorders02.15.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
Passage Bio Officially Launches
With $115.5M Series A, to develop AAV-delivered therapeutics to treat rare monogenic CNS diseases02.15.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
AbCellera & Novartis Announce Collaboration
AbCellera to apply technology to advance programs on up to ten targets elected by Novartis02.15.19
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
NeoTX, MedImmune Announce Clinical Collaboration
To support Phase 1b/2 studies investigating ANYARA in combination with AstraZeneca's IMFINZI02.11.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Eton & Sintetica Enter Supply Agreement
To obtain U.S. marketing rights to two high-volume, near-term product launch candidates.02.11.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
MedPharm & Palvella Expand Partnership
For developing a new treatment for the debilitating rare disease, pachyonychia congenita02.11.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Merck KGaA, GSK Ink $4.2B Immunotherapy Deal
Eight immuno-oncology clinical development studies ongoing or expected to commence in 2019Videos
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Evotec & Galapagos Enter Global Collaboration
Focused on a novel target for fibrosis and other indications02.07.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
Polyphor Awarded $5.6M Grant from CARB-X
To support the development of a novel OMPTA candidate to treat the deadliest and most resistant Gram-negative bacterial pathogens02.05.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Methods Development | R&D
Xencor, Genentech Enter Research & Licensing Deal
To develop and commercialize Novel IL-15 Immune Activating Cytokines02.05.19
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Neurotrope & NCI Enter Development Agreement
To develop a Phase I clinical trial testing the safety and toxicity of Bryostatin-1 in children and young adults with CD22 + leukemia and B-cell lymphoma02.04.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
MeiraGTx & Janssen Enter Gene Therapy Collaboration
To develop and commercialize gene therapies for the treatment of inherited retinal diseases01.31.19
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Fortress' Caelum Enters Partnership with Alexion
To advance the development of CAEL-101 for light chain (AL) amyloidosis01.31.19
-
Breaking News | Drug Development | Drug Discovery | Toxicology
Charles River, ToxTracker In Tox Assay Alliance
To offer access to ToxTracker to quickly screen chemicals for genotoxicity01.31.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Metrion, LifeArc Enter Drug Discovery Project
Project aims to identify novel selective small molecule modulators of a specific ion channel target01.29.19
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News
Lambda to Acquire Novum
Novum will retain its identity and will operate as a division of global CRO leader Lambda Therapeutic Research giving Lambda entry into the U.S. market01.29.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Triphase Accelerator & Celgene Partner for Cancer
For a first-in-class preclinical therapeutic targeting the WDR5 protein for the treatment of blood cancers including leukemia01.29.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
BioDuro and Advent Partner for Drug Discovery
Under the terms of the partnership, Advent has made an undisclosed majority investment in BioDuro01.28.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
B-MoGen & CytoSen Enter Research Collaboration
To develop the next generation of gene-modified natural killer cell (NK) therapies01.24.19
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Philogen Ties-up with Big Pharma
Italy-based biotech forms discovery collaborations with J&J and Celgene01.24.19
